Yıldız Mehmet, Köker Oya, Adrovic Amra, Şahin Sezgin, Barut Kenan, Kasapçopur Özgür
Department of Pediatric Rheumatology, İstanbul University-Cerrahpaşa, Cerrahpaşa School of Medicine, İstanbul, Turkey.
Department of Pediatric Rheumatology, İstanbul University, İstanbul School of Medicine, İstanbul, Turkey.
Eur J Rheumatol. 2020 Feb;7(Suppl1):S38-S47. doi: 10.5152/eurjrheum.2019.19121.
Behçet's Disease was first described by a Turkish dermatologist, Hulusi Behçet, in 1937 as a triple symptom complex; aphthous stomatitis, genital ulcers, and uveitis. Today, in light of current trials and experiments, we know that the disease may have a wider involvement with a multisystemic recurrent course, causing significant morbidity and mortality. However, there are still unanswered questions, particularly about Pediatric Behçet's Disease. Although several immunological and genetic associations have been demonstrated, the real etiologic mechanism of the disease is unclear. The diagnosis is difficult due to its rarity in childhood, the lack of validation of the diagnostic criteria obtained from adult studies, and the inadequacy of large case-controlled studies. Also, the management is challenging and controversial due to the various geographic distribution of clinical spectrum. New therapeutic options under development in light of pathogenetic hypothesis seem to be promising.
白塞病于1937年由土耳其皮肤科医生胡卢西·白塞首次描述为一种三联征,即复发性口腔溃疡、生殖器溃疡和葡萄膜炎。如今,根据当前的试验和实验,我们知道该疾病可能有更广泛的累及范围,呈现多系统复发性病程,导致显著的发病率和死亡率。然而,仍有一些问题尚未得到解答,尤其是关于儿童白塞病的问题。尽管已经证实了一些免疫和遗传关联,但该疾病真正的病因机制尚不清楚。由于其在儿童期罕见、缺乏从成人研究中获得的诊断标准的验证以及大型病例对照研究的不足,诊断较为困难。此外,由于临床谱的地理分布各异,治疗也具有挑战性且存在争议。根据发病机制假说正在研发的新治疗方案似乎很有前景。